This portion of AB 1415 lays the definitional groundwork the Health Care Affordability Board and the Department of Health Care Access and Information will use to measure statewide health spending and set accountability targets. It specifies the components of “administrative costs and profits,” what counts as “total health care expenditures,” how “affordability” is measured for consumers and purchasers, and which organizations qualify as payers, providers, physician organizations, and fully integrated delivery systems.
Why this matters: these definitions determine the denominator and numerator of the statute’s cost metrics, who falls inside regulatory targets, and which entities can be carved out as exempt. The bill’s reach extends beyond traditional insurers to private equity and hedge fund investors, management services organizations, and complex ownership structures—so the definitional choices will materially affect reporting obligations, enforcement options, and incentives for contracting and consolidation across California’s health system.
At a Glance
What It Does
Creates precise statutory definitions for terms the Board and Director will use to measure per-capita health spending and set health care cost targets, including what spending categories count and which organizations are in scope. It also authorizes the Board to set exemption standards and to consider affiliates when determining coverage.
Who It Affects
Payers (public and private), hospitals and physician organizations, fully integrated delivery systems, management services organizations, private equity and hedge fund owners, state agencies that collect spending data, and employers that purchase coverage.
Why It Matters
By expanding the spending base (for example, to include patient cost-sharing and pharmacy rebates) and defining organizational forms and ownership, the bill shapes who will face limits and reporting duties and how regulators will allocate costs and responsibility for hitting affordability targets.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The supplied text is the statute’s definitions section; it does not set targets or penalties here, but it creates the measurement tools the Board will use. First, the bill defines “administrative costs and profits” to include broad categories—administrative expenditures, additions to reserves, dividends or rebates, profits or losses, and taxes and fees—and ties that term to nonprofit health plan affiliates for fully integrated systems.
That choice ensures administrative overhead and profits are explicitly part of any total-spending calculation rather than implicitly excluded.
Second, the statute expands the concept of affordability in two parallel ways: for consumers it expressly includes the enrollee share of premiums and all forms of cost sharing applied toward maximum out-of-pocket limits; for purchasers it requires looking at premiums, actuarial value, and the “value” delivered by health spending. Those parallel definitions signal the Board must weigh both out-of-pocket burdens on patients and the financial impact on buyers like employers and the state.Third, the bill draws wide scope around who counts as a payer and provider. “Payer” covers insurers, public programs (Medi‑Cal and Medicare), third‑party administrators, and other entities that arrange payment. “Provider” lists physician organizations, hospitals, clinics, labs, imaging centers, and ambulatory surgical centers.
The physician organization label is defined by a floor—generally groups of 25 or more physicians—or by being identified as a high-cost outlier under state and federal data sources, including the Health Care Payments Data Program.Finally, the statute defines organizational forms and ownership concepts the Board must consider: fully integrated delivery systems are tied to nonprofit health plans and exclusive contracting with a single physician organization in a region; management services organizations are drawn into scope for administrative functions but excluded if they own health facilities; and private equity and hedge funds are defined so they can be traced where they control or invest in health entities. The law also instructs the Board to consider affiliates and subsidiaries when evaluating exemption requests, meaning corporate structures and capital owners will be relevant in determining regulatory coverage.
The Five Things You Need to Know
The statute explicitly lists five components of “administrative costs and profits”: administrative expenditures, net additions to reserves, rate dividends or rebates, profits or losses, and taxes and fees.
A “fully integrated delivery system” requires a nonprofit health plan, an affiliate hospital system, and an exclusive contract between that plan and a single physician organization in a geographic region.
A “physician organization” generally means groups of 25 or more physicians, but smaller groups qualify if designated as high-cost outliers based on state, federal, or HCAI data.
“Total health care expenditures” expressly include claims and encounters, non‑claims payments (capitation, salary, global budgets), patient cost sharing, administrative costs and profits, and pharmacy rebates and prescription drug costs.
The Board must consider affiliates, subsidiaries, and entities that control or are controlled by a provider when deciding whether to grant an exemption from statewide or sector-specific targets.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
What counts as administrative costs and profits
This subsection enumerates the line items the Board will treat as administrative costs and profits, including reserves, dividends/rebates, profits/losses, and taxes/fees. Practically, that forces regulators to capture both operating overhead and capital-related flows when calculating total spending—and makes reserve behavior and payout policies (like dividends or rate rebates) part of affordability calculations.
Dual definitions of affordability (consumers vs. purchasers)
The statute separates affordability into consumer and purchaser lenses. For consumers, the test centers on the total out-of-pocket burden including premiums and all forms of cost sharing; for purchasers, it adds premium costs, actuarial value, and the value yielded by spending. This creates two assessment tracks the Board must reconcile when setting targets and evaluating policy options—one centered on patient financial hardship, the other on buyer value and fiscal exposure.
Exempted providers and fully integrated delivery systems
The Board gets authority to set exemption standards and must weigh economic and operational factors—revenue, volume, high-cost outliers, and affiliate relationships—when deciding exemptions from statewide or sector targets. The fully integrated delivery system definition ties exemption and target-setting to a specific contractual and ownership structure (nonprofit plan plus exclusive physician contract), which will determine how complex systems are categorized and regulated.
Who counts as a payer and how investor ownership is treated
The payer definition covers traditional insurers, public programs, third-party administrators, and other entities that arrange payment. The statute separately defines private equity groups and hedge funds, and carves out passive capital contributors—meaning the Board will trace active investors and managers for regulatory purposes but not passive limited partners or typical banks that provide debt financing.
Who counts as a physician organization
This subsection builds a mixed test: a numerical floor (25+ physicians) plus a substantive exception for smaller groups identified as high-cost outliers. The identification mechanisms include state and federal data and the Health Care Payments Data Program, which ties cost accountability to available spending and financial reporting data sources.
Management services organizations (MSOs) in scope for administrative functions
MSOs are brought into the statute as entities that provide management and administrative support—rate negotiation, revenue cycle management, etc.—but the definition excludes entities that own health facilities. That distinction matters for attribution of administrative spending and for whether an MSO’s activities will be counted toward an affiliate provider’s numbers.
What total health care expenditures include
This subsection lists the spending categories the Board must aggregate: claims and encounters, non‑claims payments (capitation, global budgets), patient cost‑sharing, administrative costs and profits, and pharmacy rebates and drug costs. The comprehensiveness of this list expands the spending base regulators will analyze and reduces the chance that significant spending flows fall outside the statute’s accounting.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- California consumers with high cost-sharing burdens — the statute forces regulators to consider premiums and all forms of cost sharing when assessing affordability, making patient out-of-pocket burdens visible in state metrics.
- Purchasers (large employers, public employers, benefit trusts) — the purchaser-focused affordability definition requires regulators to consider premiums and actuarial value, which can support policies aimed at reducing employer premium growth or improving value.
- State regulators and the Health Care Affordability Board — the detailed definitions give the Board clearer metrics and categories to build targets, evaluate exemptions, and compare performance across regions and sectors.
- Smaller physician groups that are not high-cost outliers — the physician organization definition creates a de facto threshold (25+ physicians) so many small practices start outside the physician-organization label unless flagged as high-cost.
Who Bears the Cost
- Health plans and fully integrated delivery systems — counting administrative costs, profits, reserves, and rebate flows increases the portions of spending that regulators can scrutinize, potentially exposing these entities to targets and reporting burdens.
- Providers and entities with complex ownership chains (including private equity-backed providers) — the requirement to consider affiliates and controllers when determining exemptions increases disclosure and aggregation obligations.
- Management services organizations and investors — MSOs that perform rate negotiation and revenue cycle work and active private equity/hedge fund owners may face new scrutiny as regulators trace administrative spending and investment returns into total expenditures.
- State data and regulatory agencies (HCAI and the Department) — implementing these comprehensive definitions will require expanded data collection, reconciliation of claims/non‑claims payments, and new methodologies, creating administrative and technical costs.
Key Issues
The Core Tension
The statute aims to make California’s affordability targets comprehensive and hard‑to‑evade by counting administrative profits, patient cost sharing, and investment ownership, but that comprehensiveness trades off with measurement difficulty, increased reporting burdens, and the risk of regulatory gaps or gaming when ownership and contract structures are complex.
The statute’s precision creates implementation complexity. First, allocating “administrative costs and profits” across products, lines of business, and entities is inherently messy: insurers, plan-affiliated nonprofit entities, MSOs, and provider organizations all record overhead differently, and reserve changes or rebate timing can materially shift annual results.
Second, including pharmacy rebates and inpatient/outpatient drug costs raises net-versus-gross accounting questions; rebates can be recorded at payer or manufacturer levels, and netting those flows against drug spending requires consistent, auditable data feeds that do not yet exist in a standardized form. Third, the exemption framework gives the Board discretion but hinges on data quality and definitions of control—requiring regulators to trace affiliates, subsidiaries, and investors through ownership chains that private-equity and hedge-fund structures routinely obscure.
Fourth, several definitions create possible strategic responses. The “fully integrated delivery system” construction (nonprofit plan + exclusive physician contract) could incentivize alternative contracting to avoid the label or to replicate its favorable treatment, depending on how targets apply.
The 25‑physician threshold for physician organizations is a blunt instrument: it simplifies scope but risks arbitrary inclusion or exclusion unless the high-cost outlier methodology is tightly specified. Finally, operationalizing purchaser “value” is an evaluative task that will require new metrics linking spending to quality and efficiency outcomes—data that are often delayed or incomplete.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.